Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

A Prospective Study of the Use of Micropulse 577nm Laser Treatment in Central Serous Chorioretinopathy

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

The investigators hypothesize that application of 577nm micropulse laser in patients with CSC will prompt resolution of CSC as measured by ocular coherence tomography and best corrected visual acuity. This will be a pilot study to establish sound methods and provide some insights to the safety and efficacy of CSC treatment.

Inclusion Criteria:

• Patients with new diagnosis of CSC and no other comorbidities or prior retinal treatment
• Patients ranging from 30 to 60 years of age

Exclusion Criteria:

• Patients with no case of CSC
• Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration
• Patients with prior retinal treatment